from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2321c/rocD2

LFCtreatmentdescriptionclass of inhibitor

-0.953

Amikacinug/mL Amikacintranslation

-0.692

Cap5-10ug/mL Capreomycintranslation

-0.411

Rox10-50 ug/mL Roxithromycintranslation

-0.303

SM2-5 ug/mL Streptomycintranslation

-0.896

Tet5-10 ug/mL Tetracyclinetranslation

1.482

Rif0.2-5ug/mL Rifampicintranscription

-0.068

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.410

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.701

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.787

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.919

Clofazimine10-13 ug/mL Clofaziminerespiration

0.779

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.151

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.664

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.373

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.579

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.199

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.284

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.109

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.728

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.239

Nigericin50 uM Nigericinrespiration

0.894

TRC10-150 ug/mL Triclosanrespiration

0.293

TRZ10-25 ug/mL Thioridazinerespiration

0.220

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.713

menadione6-10 ug/mL Menadionerespiration

-0.303

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.465

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.132

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.458

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.358

NRP_1Non-replicating persistence stage 1dosRassociated

-0.326

Amp0.2mg/mL AmpicillincellWall

-0.350

Cephalexin20-100 ug/mL CephalexincellWall

-0.088

Cerulenin0.32-5 ug/mL CerulenincellWall

1.039

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.300

EMB10-20 ug/mL EthambutolcellWall

-0.779

Eta12-40 ug/mL EthionamidecellWall

-0.717

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.499

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.106

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.183

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.215

BZA0.12 mg/mL BenzamidearomaticAmides

0.044

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.430

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.782

H2O24 mM hydrogen peroxideDNAdamaging

-0.773

Levo10 ug/mL LevofloxacinDNAdamaging

-0.105

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.383

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.451

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.496

UVUV-irradiationDNAdamaging

-1.131

ARP41-4 ug/mL Antitubercular compound ARP4?

0.151

Antimycin12.5-50 ug/mL Antimycin A?

-1.267

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.023

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.349

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.572

PA8240.2-2 ug/mL PA-824?

0.204

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.224

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-1.018

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.670

methoxatin10-20 ug/mL Methoxatin?